Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Haldar, 2008, Cluster analysis and clinical asthma phenotypes, Am J Respir Crit Care Med, 178, 218, 10.1164/rccm.200711-1754OC Flood-Page, 2003, Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics, J Clin Invest, 112, 1029, 10.1172/JCI17974 Flood-Page, 2007, A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma, Am J Respir Crit Care Med, 176, 1062, 10.1164/rccm.200701-085OC Flood-Page, 2003, Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway, Am J Respir Crit Care Med, 167, 199, 10.1164/rccm.200208-789OC Leckie, 2000, Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response, Lancet, 356, 2144, 10.1016/S0140-6736(00)03496-6 Haldar, 2009, Mepolizumab and exacerbations of refractory eosinophilic asthma, N Engl J Med, 360, 973, 10.1056/NEJMoa0808991 Nair, 2009, Mepolizumab for prednisone-dependent asthma with sputum eosinophilia, N Engl J Med, 360, 985, 10.1056/NEJMoa0805435 2000, Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions, Am J Respir Crit Care Med, 162, 2341, 10.1164/ajrccm.162.6.ats9-00 Juniper, 1999, Development and validation of a questionnaire to measure asthma control, Eur Respir J, 14, 902, 10.1034/j.1399-3003.1999.14d29.x Juniper, 2005, Measurement properties and interpretation of three shortened versions of the asthma control questionnaire, Respir Med, 99, 553, 10.1016/j.rmed.2004.10.008 Juniper, 1993, Measuring quality of life in asthma, Am Rev Respir Dis, 147, 832, 10.1164/ajrccm/147.4.832 Keene, 2008, Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited, Eur Respir J, 32, 17, 10.1183/09031936.00161507 Chanez, 2007, Severe asthma in adults: what are the important questions?, J Allergy Clin Immunol, 119, 1337, 10.1016/j.jaci.2006.11.702 Romagnoli, 2007, Near-fatal asthma phenotype in the ENFUMOSA Cohort, Clin Exp Allergy, 37, 552, 10.1111/j.1365-2222.2007.02683.x Barnes, 1996, The costs of asthma, Eur Respir J, 9, 636, 10.1183/09031936.96.09040636 Godard, 2002, Costs of asthma are correlated with severity: a 1-yr prospective study, Eur Respir J, 19, 61, 10.1183/09031936.02.00232001 Djukanovic, 2004, Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma, Am J Respir Crit Care Med, 170, 583, 10.1164/rccm.200312-1651OC Corren, 2011, Lebrikizumab treatment in adults with asthma, N Engl J Med, 365, 1088, 10.1056/NEJMoa1106469 Green, 2002, Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial, Lancet, 360, 1715, 10.1016/S0140-6736(02)11679-5 Jayaram, 2006, Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations, Eur Respir J, 27, 483, 10.1183/09031936.06.00137704 Powell, 2011, Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial, Lancet, 378, 983, 10.1016/S0140-6736(11)60971-9 Moore, 2010, Identification of asthma phenotypes using cluster analysis in the severe asthma research program, Am J Respir Crit Care Med, 181, 315, 10.1164/rccm.200906-0896OC Bafadhel, 2011, Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers, Am J Respir Crit Care Med, 184, 662, 10.1164/rccm.201104-0597OC Heaney, 2010, Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry, Thorax, 65, 787, 10.1136/thx.2010.137414 Pavord, 2010, Mepolizumab in refractory eosinophilic asthma, Thorax, 65, 370, 10.1136/thx.2009.122697 Greulich, 2012, FENO and blood eosinophil count as surrogate markers of eosinophilic airway inflammation in patients with severe asthma, Eur Respir J, 36, 1005s Adinoff, 1983, Steroid-induced fractures and bone loss in patients with asthma, N Engl J Med, 309, 265, 10.1056/NEJM198308043090502